The impact of nucleic acid secondary structure on PNA hybridization

Drug Discovery Today

Volumn 8, Issue 5, 2003, Pages 222-228

  Armitage, Bruce A ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; OLIGOMER; PEPTIDE NUCLEIC ACID;

DNA SEQUENCE; HUMAN; KINETICS; MOLECULAR HYBRIDIZATION; NONHUMAN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; PROTEIN TERTIARY STRUCTURE; REVIEW; RNA SEQUENCE; THERMODYNAMICS;

NUCLEIC ACID HYBRIDIZATION; PEPTIDE NUCLEIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

EID: 0037335318     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02611-4     Document Type: Review

References (69)

1. Watson J.D., Crick F.H.C. A structure for deoxyribose nucleic acid. Nature. 171:1953;737-738.
2. Nielsen P.E., et al. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science. 254:1991;1498-1500.
3. Nielsen P.E., Haaima G. Peptide nucleic acid (PNA). A DNA mimic with a pseudopeptide backbone. Chem. Soc. Rev. 26:1997;73-78.
4. Uhlmann E., et al. PNA: synthetic polyamide nucleic acids with unusual binding properties. Angew. Chem. Int. Ed. 37:1998;2796-2823.
5. Egholm M., et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature. 365:1993;566-568.
6. Egholm M., et al. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J. Am. Chem. Soc. 114:1992;1895-1897.
7. Demidov V.V., Frank-Kamenetskii M.D. Sequence-specific targeting of duplex DNA by peptide nucleic acids via triplex strand invasion. Methods. 23:2001;108-122.
8. Møllegaard N.E., et al. Peptide nucleic acid. DNA strand displacement loops as artificial transcription promoters. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3892-3895.
9. Wang G., et al. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression. J. Mol. Biol. 313:2001;933-940.
10. Liu B., et al. Toward synthetic transcription activators: recruitment of transcription factors to DNA by a PNA-peptide chimera. J. Am. Chem. Soc. 124:2002;1838-1839.
11. Dias N., et al. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol. 294:1999;403-416.
12. Doyle D.F., et al. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry. 40:2001;53-64.
13. Dias N., et al. RNA hairpin invasion and ribosome elongation arrest by mixed base PNA oligomer. J. Mol. Biol. 320:2002;489-501.
14. Good L., Nielsen P.E. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. Biotechnol. 16:1998;355-358.
15. Good L., et al. Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 19:2001;360-364.
16. Demidov V.V., Frank-Kamenetskii M.D. PNA directed genome rare cutting. Nielsen P.E., Egholm M. Peptide Nucleic Acids: Protocols and Applications. 1999;163-174 Horizon Scientific Press.
17. Veselkov A.G., et al. PNA as a rare genome-cutter. Nature. 379:1996;214.
18. Veselkov A.G., et al. A new class of genome rare cutters. Nucleic Acids Res. 24:1996;2483-2488.
19. Demidov V.V., Frank-Kamenetskii M.D. PNA openers and their applications. Nielsen P.E. Peptide Nucleic Acids: Methods and Protocols. 2002;119-130 Humana Press.
20. Izvolsky K.I., et al. Sequence-specific protection of duplex DNA against restriction and methylation enzymes by pseudocomplementary PNAs. Biochemistry. 39:2000;10908-10913.
21. Ørum H., et al. Sequence-specific purification of nucleic acids by PNA-controlled hybrid selection. Biotechniques. 19:1995;472-480.
22. Zelphati O., et al. Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA. Hum. Gene Ther. 10:1999;15-24.
23. Demidov V.V., et al. Electron microscopy mapping of oligopurine tracts in duplex DNA by peptide nucleic acid targeting. Nucleic Acids Res. 22:1994;5218-5222.
24. Kuhn H., et al. An earring for the double helix: assembly of topological links comprising duplex DNA and a circular oligodeoxynucleotide. J. Biomol. Struct. Dyn. S2:2000;221-225.
25. Zelphati O., et al. PNA-dependent gene chemistry: stable coupling of peptides and oligonucleotides to plasmid DNA. Biotechniques. 28:2000;304-316.
26. Nielsen P.E., Christensen L. Strand displacement binding of a duplex-forming homopurine PNA to a homopyrimidine duplex DNA target. J. Am. Chem. Soc. 118:1995;2287-2288.
27. Ishihara T., Corey D.R. Rules for strand invasion by chemically modified oligonucleotides. J. Am. Chem. Soc. 121:1999;2012-2020.
28. Zhang X., et al. Strand invasion by mixed base PNAs and a PNA-peptide chimera. Nucleic Acids Res. 28:2000;3332-3338.
29. Demidov V.V., et al. Kinetics and mechanism of polyamide ('peptide') nucleic acid binding to duplex DNA. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2637-2641.
30. Kuhn H., et al. An experimental study of mechanism and specificity of peptide nucleic acid (PNA) binding to duplex DNA. J. Mol. Biol. 286:1999;1337-1345.
31. Egholm M., et al. Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res. 23:1995;217-222.
32. Griffith M.C., et al. Single and bis peptide nucleic acids as triplexing agents: binding and stoichiometry. J. Am. Chem. Soc. 117:1995;831-832.
33. Kaihatsu K., et al. Enhanced strand invasion by peptide nucleic acid-peptide conjugates. Biochemistry. 41:2002;11118-11125.
34. Lohse J., et al. Double duplex invasion by peptide nucleic acid: A general principle for sequence-specific targeting of double-stranded DNA. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11804-11808.
35. Demidov V.V., et al. Kinetics and mechanism of the DNA double helix invasion by pseudocomplementary peptide nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5953-5958.
36. Soyfer V.N., Potaman V.N. Triple-Helical Nucleic Acids. 1996;Springer-Verlag.
37. Siddiqui-Jain A., et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11593-11598.
38. Gellert M. V(D)J recombination: RAG proteins, repair factors and regulation. Annu. Rev. Biochem. 71:2002;101-132.
39. Kushon S.A., et al. Effect of secondary structure on the thermodynamics and kinetics of PNA hybridization to DNA hairpins. J. Am. Chem. Soc. 123:2001;10805-10813.
40. Varani G. Exceptionally stable nucleic acid hairpins. Annu. Rev. Biophys. Biomol. Struct. 24:1995;379-404.
41. Armitage B., et al. Hairpin-forming peptide nucleic acid oligomers. Biochemistry. 37:1998;9417-9425.
42. Williamson J.R. G-quartet structures in telomeric DNA. Annu. Rev. Biophys. Biomol. Struct. 23:1994;703-730.
43. Cech T.R. Life at the end of the chromosome: telomeres and telomerase. Angew. Chem. Int. Ed. Engl. 39:2000;35-43.
44. Arthanari H., Bolton P.H. Functional and dysfunctional roles of quadruplex DNA in cells. Chem. Biol. 8:2001;221-230.
45. Darnell J.C., et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 107:2001;489-499.
46. Andreola M-L., et al. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. Biochemistry. 40:2001;10087-10094.
47. Wang K.Y., et al. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. Biochemistry. 32:1993;1899-1904.
48. Okazawa A., et al. In vitro selection of hematoporphyrin binding DNA aptamers. Bioorg. Med. Chem. Lett. 10:2000;2653-2656.
49. Riou J.F., et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2672-2677.
50. Bock L.C., et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 355:1992;564-566.
51. Datta B., Armitage B.A. Hybridization of PNA to structured DNA targets: quadruplex invasion and the overhang effect. J. Am. Chem. Soc. 123:2001;9612-9619.
52. Tomac S., et al. Ionic effects on the stability and conformation of peptide nucleic acid complexes. J. Am. Chem. Soc. 118:1996;5544-5552.
53. Taneja K.L. Localization of trinucleotide repeat sequences in myotonic dystrophy cells using a single fluorochrome-labeled PNA probe. Biotechniques. 24:1998;472-476.
54. Boffa L.C., et al. Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1901-1905.
55. Boffa L.C., et al. Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence. J. Biol. Chem. 271:1996;13228-13233.
56. Voelker J., et al. Conformational energetics of stable and metastable states formed by DNA triplet repeat oligonucleotides: implications for triplet expansion diseases. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14700-14705.
57. Hamilton S.E., et al. Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6:1999;343-351.
58. Villa R., et al. Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett. 473:2000;241-248.
59. Good L., Nielsen P.E. Progress in developing PNA as a gene-targeted drug. Antisense Nucleic Acid Drug Devel. 7:1997;431-437.
60. Good L., Nielsen P.E. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2073-2076.
61. Lee R., et al. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription. Biochemistry. 37:1998;900-910.
62. Boulmé F., et al. Modified (PNA, 2′-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription. Nucleic Acids Res. 26:1998;5492-5500.
63. Demidov V.V., et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48:1994;1310-1313.
64. Efimov V.A., et al. Synthesis and evaluation of some properties of chimeric oligomers containing PNA and phosphono-PNA residues. Nucleic Acids Res. 26:1998;566-575.
65. Kristensen E. In vitro and in vivo studies on pharmacokinetics and metabolism of PNA constructs in rodents. Nielsen P.E. Peptide Nucleic Acids: Methods and Protocols. 2002;259-269 Humana Press.
66. Obika S., et al. Stability and structural features of the duplexes containing nucleoside analogs with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett. 39:1998;5401-5404.
67. Singh S.K., et al. LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem. Commun. 1:1998;455-456.
68. Singh S.K., Wengel J. Universality of LNA-mediated high-affinity nucleic acid recognition. Chem. Commun. 1:1998;1247-1248.
69. Braasch D.A., Corey D.R. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol. 8:2001;1-7.